Molecular fate-mapping of serum antibody responses to repeat immunization.
Molecular fate-mapping of serum antibody responses to repeat immunization.
复制标题
DOI:
10.1038/s41586-023-05715-3
复制
发表时间:
2023-03
期刊:
影响因子:
64.8
通讯作者:
Victora, Gabriel D. D.
中科院分区:
文献类型:
--
作者:
Schiepers, Arien;van't Wout, Marije F. L.;Greaney, Allison J. J.;Zang, Trinity;Muramatsu, Hiromi;Lin, Paulo J. C.;Tam, Ying K. K.;Mesin, Luka;Starr, Tyler N. N.;Bieniasz, Paul D. D.;Pardi, Norbert;Bloom, Jesse D. D.;Victora, Gabriel D. D.
The protective efficacy of serum antibody results from the interplay of antigen-specific B cell clones of different affinities and specificities. These cellular dynamics underlie serum-level phenomena such as “Original Antigenic Sin” (OAS), a proposed propensity of the immune system to rely repeatedly on the first cohort of B cells engaged by an antigenic stimulus when encountering related antigens, in detriment of inducing de novo responses. OAS-type suppression of new, variant-specific antibodies may pose a barrier to vaccination against rapidly evolving viruses such as influenza and SARS-CoV-2. Precise measurement of OAS-type suppression is challenging because cellular and temporal origins cannot readily be ascribed to antibodies in circulation; thus, its impact on subsequent antibody responses remains unclear. Here, we introduce a molecular fate-mapping approach in which serum antibodies derived from specific cohorts of B cells can be differentially detected. We show that serum responses to sequential homologous boosting derive overwhelmingly from primary cohort B cells, while later induction of new antibody responses from naïve B cells is strongly suppressed. Such “primary addiction” decreases sharply as a function of antigenic distance, allowing reimmunization with divergent viral glycoproteins to produce de novo antibody responses targeting epitopes absent from the priming variant. Our findings have implications for the understanding of OAS and for the design and testing of vaccines against evolving pathogens.
登录
查看更多内容
影响因子:
64.8
作者:
Gaebler C;Wang Z;Lorenzi JCC;Muecksch F;Finkin S;Tokuyama M;Cho A;Jankovic M;Schaefer-Babajew D;Oliveira TY;Cipolla M;Viant C;Barnes CO;Bram Y;Breton G;Hägglöf T;Mendoza P;Hurley A;Turroja M;Gordon K;Millard KG;Ramos V;Schmidt F;Weisblum Y;Jha D;Tankelevich M;Martinez-Delgado G;Yee J;Patel R;Dizon J;Unson-O'Brien C;Shimeliovich I;Robbiani DF;Zhao Z;Gazumyan A;Schwartz RE;Hatziioannou T;Bjorkman PJ;Mehandru S;Bieniasz PD;Caskey M;Nussenzweig MC
通讯作者:
Nussenzweig MC
影响因子:
16.8
作者:
Henry C;Palm AE;Krammer F;Wilson PC
通讯作者:
Wilson PC
影响因子:
24.8
作者:
Kuraoka, Masayuki;Yeh, Chen-Hao;Bajic, Goran;Kotaki, Ryutaro;Song, Shengli;Windsor, Ian;Harrison, Stephen C.;Kelsoe, Garnett
通讯作者:
Kelsoe, Garnett
影响因子:
8.8
作者:
Han J;Schmitz AJ;Richey ST;Dai YN;Turner HL;Mohammed BM;Fremont DH;Ellebedy AH;Ward AB
通讯作者:
Ward AB
DOI:
10.1084/jem.124.3.347
发表时间:
1966-09-01
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Fazekas de St Groth;Webster RG
通讯作者:
Webster RG